MIT Technology Review @techreview
In the fall, it became clear that manufacturers had overestimated how quickly they could distribute doses, according to Deacon Maddox, Operation Warp Speed’s chief of plans, operations, and analytics and a former MIT fellow. This led to some of the first stumbles in the rollout. https://t.co/GhF0Rk1Uxe — PolitiTweet.org
